PD
PagerDuty, Inc.
Latest price
As of Oct 26, 2026, 6:42 PM EDT · Market data by Massive
Market cap
$1.4B
Volume
1.3M
Previous close
$17.49
Day range
$17.35 – $17.85
Listed
Apr 11, 2019
Coverage
4 articles
Price performance
Recent trading
Newsroom
Latest PD coverage
PagerDuty In Play? Why Strategic Buyers & PE Firms Are Circling The Digital Ops Leader
PagerDuty, the San Francisco-based digital operations platform, is reportedly exploring a potential sale after receiving inbound acquisition interest.
PagerDuty Inc: Is A Blockbuster Sale On The Horizon? Key Insights On Why Top Investors Could Be Circling Tech Major!
Tech player, PagerDuty has entered the spotlight due to a Bloomberg report that unveiled the company's consultation with advisers over a possible sale.
Innovent buys Chinese rights to Incyte drugs for $40M upfront
[ad_1] Innovent Biologics has bagged the Chinese rights to three clinical-phase oncology and hematology drugs in growth at Incyte. The agreement sees Innovent pay $40 million upfront and commit to about $350 million in milestones for a trio of drugs which might be in section 2 and 3 testing within the West. China’s Innovent put ...
.jpg&w=3840&q=75)
Axovant buys more gene therapies, setting it up for a busy 2019
[ad_1] Axovant has licensed two gene therapies from the University of Massachusetts Medical School (UMMS). The deal accelerates Axovant’s evolution into a gene remedy specialist by giving it management of two belongings which might be in or close to the clinic. Following the failures of intepirdine and nelotanserin, Axovant purged its pipeline of small molec